Thyroid hormone administered in vivo increased carrier-mediated (atractyloside-sensitive) ADP uptake by rat liver mitochondria. 3 Days after a single large dose of triiodothyronine (20 ;g/100 g of body weight), mitochondrial uptake of ADP measured at 60 was 2.35 4 0.17 nmol/min per mg of protein, compared with an uptake of 1.81 i 0.19 nmol/min per mg of protein in mitochondria from untreated rats (P < 0.025). Cyanide (1.33 mM) had no effect on ADP uptake by mitochondria from either untreated or triiodothyronine-treated animals. Uptake of ADP by mitochondria from thyroidectomized rats treated with thyroxine for 7 days was 2.89 4 0.40 nmol/min per mg in mitochondria from thyrotoxic rats (20 ug of thyroxine per 100 g per day) and 1.98 -0.22 nmol/min per mg in mitochondria from euthyroid rats (2 ug of thyroxine per 100 g per day) (P < 0.025). Mitochondria from both untreated and thyroid hormone-treated rats displayed a highly significant linear correlation between ADP uptake and ADP-dependent (i.e., state 3 minus state 4) oxygen consumption. There was, however, no difference in respiratory control ratios between mitochondria from euthyroid and thyrotoxic animals. Administration of dinitrophenol (2 mg/100 g) also stimulated carrier-mediated ADP uptake, but respiratory control of mitochondria from dinitrophenol-treated animals was virtually abolished. Triiodothyronine in vitro, at concentrations of 100 and 0.1 nM, appeared to inhibit rather than stimulate the uptake of mitochondrial ADP. The relationship between these observations and the clinical manifestations of thyrotoxicosis is discussed from the point of view of the possible effects of increased mitochondrial ADP transport on oxidative phosphorylation and adenosyl nucleotide metabolism.
It has long been known that an increase in metabolic rate follows administration of a sufficient dose of thyroid hormone. Animals treated with large doses of thyroxine manifest an increased rate of oxygen consumption, a rise in body temperature, and a loss in weight, all consequent to an increase in the rate of oxidation of substrate (1, 2) . Since most substrate oxidation takes place in mitochondria, many studies on the mechanism of action of thyroid hormone have involved these organelles. These studies have shown, for example, that * To whom to address correspondence. thyroid hormone increases the rate of mitochondrial oxidation of succinate, glutamate, ,-hydroxybutyrate, and isocitrate (3); the activity of the electron transport chain is increased without an increase in the concentrations of the chain components (4); and there is an increase in the activity of membrane-bound a-glycerophosphate dehydrogenase (5) .
In addition, thyroid hormone affects mitochondrial swelling (6, 7) and respiratory control (8) , but these effects are only observed with rather large doses of hormone.
The mitochondrion is composed of an outer membrane, an inner membrane, and two spaces: the intermembrane space, which lies between the membranes, and the matrix, which is enclosed within the inner membrane. The matrix contains the substrates necessary for oxidative phosphorylation, a process that takes place on the inner surface of the inner membrane (9) . It has recently been shown that the transport of ADP, one of the substrates of oxidative phosphorylation into the matrix, is a carrier-mediated process in which an ADP molecule is conveyed into the matrix in exchange for an ATP molecule, which is then transported out of the mitochondrion (10, 11). Since there is evidence that under physiological conditions, the rates of both substrate oxidation and oxidative phosphorylation are limited by the availability of ADP (12) (13) (14) , we thought it of interest to investigate whether thyroid hormone might increase the availability of ADP through an effect on the carrier-mediated transport.
MATERIALS AND METHODS
Male and female CD rats weighing 250-400 g were obtained from the Charles River Breeding Laboratories. In some cases rats underwent surgical thyroidectomy before delivery. Where normal rats were used, the control and treated groups each contained about the same proportion of animals of a given sex. Thyroidectomized rats were all males.
Thyroxine and triiodothyronine were obtained from Sigma mM EGTA. The livers were squeezed through an aluminumplated garlic press, and the resulting pulp was homogenized together with 5 volumes of sucrose-Tris-EGTA solution, at slow speed in a Potter-Elvehjem glass homogenizer with a loose-fitting Teflon pestle. The homogenate was centrifuged twice for 10 min at 1000 X g to remove the debris. The supernatant was then centrifuged at 6000 X g for 10 min. The resulting pellet was washed once in the sucrose-Tris-EGTA solution and then once in sucrose-Tris without EGTA. The pellet was centrifuged at 6000 X g for 10 min after each wash. The final pellet was suspended in about 2 ml of sucroseTris. Care was taken to keep the mitochondria, solutions, and instruments ice-cold at all times.
Mitochondrial Oxygen Uptake and Respiratory Control were determined by the method of Estabrook (15) After 10 sec, ADP uptake was arrested by the rapid addition of 100 Ml of 0.2 mM potassium atractyloside, a powerful specific competitive inhibitor of mitochondrial ADP-ATP exchange [K = 20 nM (11)1. Immediately, 100 Al of the reaction mixture was drawn into a microliter syringe and injected into the center of a Millipore paper filter (0.65-/hm pore size, 2.5-cm diameter), which was held in a filtration apparatus under reduced pressure. The mitochondria were quickly washed with 10 ml of 0.15 M NaCl solution. The entire operation was conducted in a cold room at 60. From beginning to end, the procedure took less than 25 sec.
The filter was removed from the apparatus, placed in a liquid scintillation vial containing 15 ml of Bray's solution, and allowed to stand overnight to permit the filter to dissolve. After vigorous shaking to disrupt the mitochondrial precipitate, the sample was counted in a Mark I liquid scintillation counter (Nuclear Chicago). Counting efficiency was determined by internal standardization with [14C]toluene of known specific activity.
Nonspecific ADP uptake was determined similarly, except that mitochondria were added after the addition of atractyloside. For a given set of mitochondria, total ADP uptake was determined in duplicate, and nonspecific uptake was determined once. Carrier-mediated ADP transport was calculated 
RESULTS
Initial experiments were performed with two groups of normal rats. Animals from each group were treated either with a large dose of triiodothyronine (20 ;&g/100 g) or with an equivalent volume of NaOH-saline, administered as a single intraperitoneal injection. Animals from one group were killed 20 hr after injection, while animals from the other group were killed 3 days after treatment with triiodothyronine. Liver mitochondria were prepared as previously described and tested for oxygen consumption with succinate as the oxidizable substrate, as well as for carrier-mediated ADP uptake.
Results of the determinations of mitochondrial ADP uptake are shown in Table 1 . Significant differences in ADP uptake between the two groups of animals were observed. In mitochondria from rats killed 20 hr after injection, atractylosidesensitive ADP uptake was 25% greater in mitochondria from triiodothyronine-treated animals than in those from control animals (P < 0.1). At 3 days, the time at which effects on basal metabolic rate are greatest (17) , the difference between the two groups was 30% and was now statistically significant (P < 0.025). It thus appears that treatment with triiodothyronine increased carrier-mediated ADP uptake by ratliver mitochondria.
Oxygen uptake by mitochondria from triiodothyroninetreated animals was also increased when compared with values in controls. Moreover, there was a close correlation between ADP-dependent (state 3 minus state 4) oxygen uptake and carrier-mediated ADP transport into the mitochondrial matrix ( Fig. 1) , a finding consistent with the previously reported dependence of mitochondrial substrate oxidation on availability of ADP (12) (13) (14) . Nevertheless, the respiratory control ratios of the two groups were the same (2.95 ± 0.17 and 2.83 ± 0.14). Thus, at the dose given, triiodothyronine increased both carrier-mediated ADP uptake and ADPdependent respiration in rat-liver mitochondria, but did not appear to affect respiratory control.
Similar results were obtained with rats treated with thyroxby subtraction of the value of nonspecific ADP uptake from ine. For these experiments, thyroidectomized rats were used. 2 Weeks after thyroidectomy, the animals were divided into two groups. One group received seven daily intraperitoneal injections of 2 ,g of thyroxine/100 g of body weight (10 Msg/ml in 2% bovine-serum albumin), a quantity sufficient to restore the animals to euthyroid status; the other group received a similar number of injections of thyroxine (100 Mg/ml in 2% bovine-serum albumin), but at the 10-fold greater dose of 20 Mg/100 g. 24 hr after the final injection, the animals were killed, liver mitochondria were prepared, and determinations of oxygen consumption and ADP uptake were performed as described above. Uptake of ADP in mitochondria from rats made thyrotoxic with thyroxine was 34% greater (P < 0.025) than in mitochondria of euthyroid animals ( Numbers in parentheses represent the number of animals used in each experiment. The difference between the two groups is significant at the level of P < 0.025. nificant correlation between ADP-dependent oxygen uptake and carrier-mediated ADP transport was also observed (Fig.  2) . Finally, despite the differences between the two groups of thyroxine-treated animals with respect to mitochondrial ADP uptake and oxygen consumption, respiratory control of euthyroid mitochondria (2.84 ± 0.23) was almost identical with that of thyrotoxic mitochondria (2.79 i 0.20). Thus, the findings obtained with the thyroxine-treated animals accord in all respects with those obtained with the triiodothyroninetreated animals. Moreover, regression equations for the relation between ADP uptake and ADP-dependent oxygen uptake in the two groups of experiments were very similar ( Figs. 1 and 2 ). The slightly greater slope seen in experiments with triiodothyronine may reflect the slightly higher temperature (340) at which oxygen uptake was measured with triiodothyronine, compared to thyroxine (300).
Although uptake experiments were performed in the absence of oxidizable substrate, it could be argued that the differences in the rates of uptake of ADP by mitochondria from euthyroid and hyperthyroid animals were a consequence of differences in the rates of oxidation of endogenous substrates by the two groups of mitochondria. Evidence against this possibility was provided by the observation that cyanide had no effect on ADP uptake by mitochondria from either untreated or triiodothyronine-treated animals. The ratios of mitochondrial ADP uptake rates in the absence and presence of cyanide (1.33 mM KCN) were 1.00 ± 0.08 and 0.99 4 0.06 for mitochondria from untreated rats (5 animals) and triiodothyronine-treated rats (4 animals), respectively.
Experiments were also performed to determine whether triiodothyronine in vitro has a direct effect on mitochondrial ADP uptake. ADP uptake was determined in mitochondria from the livers of normal rats in the absence and presence of triiodothyronine. ADP uptake was measured both before and after incubation of the mitochondria with triiodothyronine. For these experiments a total of five animals was used. Mitochondria prepared by the usual technique were diluted to a concentration of 30 mg of protein per ml of sucrose-Tris to which sufficient triiodothyronine had been added to bring the final concentration to that indicated in Table 3 . A portion of these mitochondria was assayed immediately, while another portion was assayed after incubation for 60 min at 230. In all instances, triiodothyronine was present in the ADP-uptake assay mixture at the concentration shown in Table 3 . To avoid adsorption of triiodothyronine to the walls of the vessel, all operations subsequent to the preparation of the mitochondria were performed in polyethylene tubes. No increase in mitochondrial ADP uptake was produced by exposure of mitochondria to triiodothyronine either before or during the period of ADP accumulation (Table 3) . Rather, mitochondrial uptake of ADP was decreased significantly in the presence of triiodothyronine.
The increase in basal metabolic rate and body temperature seen in animals with thyrotoxicosis can also be produced by the administration of 2,4-dinitrophenol, an agent that uncouples oxidative phosphorylation (18) . These similarities between the effect of dinitrophenol and thyrotoxicosis led us to study the effect of exposure to dinitrophenol in vivo on mitochondrial ADP transport. For these experiments, four pairs of normal rats were used. One animal from each pair was injected intraperitoneally with sterile sodium dinitrophenolate (pH 7.4) in 0.9% NaCl (2 mg/kg of the freshly prepared solution), while the other was given 0.9% NaCl alone. After 90 min (18) , the animals were killed, liver mitochondria were prepared, and ADP uptake and oxygen consumption were assayed. With dinitrophenol, as with both thyroxine and triiodothyronine, there was an increase in mitochondrial uptake of ADP (3.77 i 0.22 against 2.36 41 0.22 nmol/min per mg of protein; P < 0.05). However, the changes induced by dinitrophenol were substantially larger than those produced by either of the thyroid hormones. In further contrast to the effects seen with thyroid hormone, and in confirmation of earlier reports, respiratory control of mitochondria obtained from dinitrophenol-treated animals was virtually abolished (1.26 4 0.15 against a normal value of 2.72 zh 0.23; P < 0.05).
DISCUSSION
These experiments have shown that the in vivo administration of triiodothyronine or thyroxine in doses sufficient to produce thyrotoxicosis in rats led to an increase in the rate of uptake of ADP by liver mitochondria. Presumably, this uptake was accompanied by the discharge of an equivalent amount of ATP from the mitochondrial matrix. An increase in mitochondrial oxygen consumption proportional to the increase in ADP uptake was also observed. There was, however, no evidence that either hormone caused an uncoupling of oxidative phosphorylation, since respiratory control ratios in the thyrotoxic and euthyroid groups were the same. The last result is in accord with previous observations in tissues from both animals made thyrotoxic (1) and thyrotoxic patients (19) .
Even though the ADP-ATP exchange rate correlated well with the rate of ADP-dependent oxygen uptake, the difference in the temperatures at which the two reactions were measured precluded a direct comparison of their absolute velocities. From the measurements made at 6°, however, an estimate can be made of the ADP-ATP exchange rate at the temperature at which oxygen uptake was measured. This estimate is based on the observation that the Arrhenius plot for the ADP-ATP exchange reaction is linear between 10 and 250 (14) . If we assume that the plot is also linear at temperatures slightly greater than 250, the activation energy of 28 kcal obtained from this plot can be used to calculate that an increase in the ADP-ATP exchange rate of 1 nmol/min per mg at 6°, the temperature at which the exchange reaction was measured, corresponds to an increase of 37 nmol/min per mg at 30°, the temperature at which ADP-dependent oxygen uptake was measured. Application of this factor to the data of Fig. 2 shows that at 30°, an increase in ADP transport of 3.0 nmol/min per mg of protein is accompanied by an increase in oxygen uptake of 1 nanoatom/min per mg of protein. The difference in uptake of ADP between mitochondria incubated in the presence or absence of triiodothyronine is significant at the level of P < 0.05 for all cases.
The ratio of these two values agrees surprisingly well with the figure of 2.0 expected on the basis of the P:0 ratio of mitochondria performing oxidative phosphorylation with succinate.
An increase in ADP uptake also followed administration of dinitrophenol. This result is in agreement with the observations of previous workers (10) , who found that dinitrophenol stimulated mitochondrial uptake of both ADP and ATP. This effect was accompanied by a loss of specificity of nucleotide uptake that normally favors ADP. In the presence of dinitrophenol, ADP and ATP were transported indiscriminately into the mitochondrial matrix.
In contrast to the effect observed when triiodothyronine was administered in vivo, the addition of this hormone in vitro was found to inhibit ADP uptake. Additional investigation will be necessary before the significance of the difference between the in vivo and in vitro actions of thyroid hormone becomes clear.
The fact that there was no oxidizable substrate present in the reaction mixture in which ADP uptake was measured and the observation that cyanide was without effect on ADP uptake indicate that the increase in nucleotide transport cannot be ascribed to an increase in the rate of oxidation of substrate. Conversely, however, it is possible that the increase in oxygen consumption observed in thyrotoxic mitochondria may reflect increased availability of ADP as a substrate for oxidative phosphorylation. An additional observation supporting this conclusion is the similarity of the correlation between ADP uptake and ADP-dependent oxygen consumption for triiodothyronine-and thyroxine-treated animals. Such a finding would be expected if the thyroid hormone-induced increase in mitochondrial oxygen consumption was a consequence of an increase in ADP uptake. Many of the changes in mitochondrial function reported to be induced by thyroid hormone may be due to an increase in the rate of oxidative phosphorylation that would accompany an increased rate of transport of ADP into the mitochondrion, if in fact ADP availability is the limiting parameter in mitochondiial func- resulting from an increased output of ATP by the mitochondrion. Such an increase in energy charge would be expected to be accompanied by an increase in the activity of ATP-consuming enzymes due to a direct effect of energy charge on existing enzymes (20, 21) and perhaps also due to a stimulation of synthesis of new enzymes. Ismail-Beigi and Edelman recently reported a rise in membrane-bound Na,Kdependent ATPase induced by high doses of thyroid hormone (22, 23) . This increase might be the result of an alteration in the energy charge of the cell, although alternatively it might represent an independent action of the hormone. In any case, the additional ADP produced as a consequence of the increase in activity of Na,K-dependent ATPase and other ATPconsuming reactions, added to mitochondria whose capacity to take up the nucleotide is already augmented, would lead to still further increases in the rate of oxidative phosphorylation. The end result would be an increase in the rate of turnover of both ADP and oxidizable substrate. These considerations suggest the possibility that certain of the clinical and biochemical manifestations of thyrotoxicosis can be attributed at least in part to an effect of thyroid hormone on mitochondrial nucleotide transport.
